-
Anthem Biosciences Plans RS 3,395 Cr IPO
Chandigarh, January 1, 2025: Anthem Biosciences Limited, an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing has filed the draft red herring prospectus (DRHP) with capital markets regulator, SEBI to raise funds through an initial public offering (IPO). Ajay Bhardwaj (Chairman, MD
Search
About
At NexGen Consulting, we specialize in strategic media planning that helps brands secure the best possible coverage—across both digital and print media. With a focus on visibility, credibility, and audience engagement, we ensure your message reaches the right people, at the right time, through the right platforms.
As a results-driven media consulting agency, we work closely with businesses, startups, and professionals to build strong media presence and brand authority. Whether you need features in top publications, digital news coverage, influencer reach, or targeted content placement, our team ensures maximum impact with smart, data-backed planning.
Archive
Categories
Recent Posts
- Telangana’s Biggest Juice-Line Manufacturing Facility Inaugurated in Hyderabad
- Pravasi Bharatiya Sangeet & Nritya Mahotsav 2026 to Celebrate Global Indian Classical Arts in Kolkata
- AD Ports Group Signs AED 840 Million Land Sale Agreement with Danube Properties
- Jaro Education and Delhi Technological University announceda collaboration to launch industry-focused online degree programs and strengthen workforce upskilling
- Sri Vidhya Nilayam, Wins ‘Spirit of Mylapore’ Award 2026 from Sundaram Finance
Gallery







